New cryptocurrency raises awareness on breast, cervical cancer in South Africa

After its successful Initial Coin Offering (IPO) during the mid of 2018, it was able to make significant progress in its objective to enhance social and …

During the first phase of this year, Safcoin, an exclusive African cryptocurrency, announced its process of outlining growth roadmap that included unveiling a third support centre and expanding in Africa. After its successful Initial Coin Offering (IPO) during the mid of 2018, it was able to make significant progress in its objective to enhance social and economic growth in the country.

Now, the Cancer Association of South Africa in joint collaboration with Safcoin has launched the first ever Crypto Pink Friday with an objective to raise cervical and breast cancer awareness. It (CANSA) encourages women to get screened for cervical and breast cancer. Safcoin Pink Friday will take place on August 30, 2019.

According to the 2014 National Cancer Registry (NCR), breast cancer is the most common among the South African women with a lifetime risk of one in 27. Whereas, the study shows cervical cancer is the leading cause of cancer deaths and the second most commonly diagnosed cancer (excluding basal cell carcinoma) among women. The estimated life-time risk among all women in South Africa is 1:42.

The researchers have further revealed through their surveys that women suffer delay in screening or seeking appropriate care due to stigma, shame and having limited knowledge of symptoms including misconceptions. Thus, the first ever Crypto Pink Friday campaign (added with cancer-reduction programmes) with severe support from the Cancer Association of South Africa (CANSA) will bring health awareness to the South African women.

On the other hand, the cryptocurrency lovers will enjoy all kind of trading fees at half price with a percentage being donated to CANSA on the day. The crypto aficionados can deposit funds and purchase Safcoin on their official website on August 30 Safcoin Pink Friday to get 50 percent discount. “Instead of distributing an airdrop deal for Safcoin we decided on a Pink Friday drive where we offer half price deals on the mining pool packages and donate a percentage of all the sales to CANSA,” Michela Ferreira, co-founder and Chief Communications Officer said.

Safcoin intends to get hold of the tracks that cryptocurrency can positively affect Africa. “We are not here to overthrow the existing financial system, but rather tap into the numerous benefits of crypto for Africa by developing use case technology for every individual to benefit from the positives of cryptocurrency, all while maintaining the highest levels of business ethics and standards,” Ferreira added.

Also Read: WFP tweets project with Canadian govt to break girls’ educational barrier in Niger

Related Posts:

  • No Related Posts

WebPT secures significant investment from Warburg Pincus

Global private equity firm Warburg Pincus is to acquire a majority interest in WebPT from previous investor, Battery Ventures. Since its launch in 2008, …

Global private equity firm Warburg Pincus is to acquire a majority interest in WebPT from previous investor, Battery Ventures.

Since its launch in 2008, WebPT has maintained a track record of steady growth. Today, it provides electronic medical record (EMR) and practice management software for outpatient physical therapists, occupational therapists and speech-language pathologists.

The fast-growing healthcare software-as-a-service (SaaS) company – which was recently named to the Inc. 5000 list for the seventh-consecutive year – has become the category leader in its space with 85,000 customers at more than 15,000 clinics across the US and its territories.

“Warburg Pincus has an unrivalled history of success in healthcare and technology, and their investment speaks volumes about their belief in WebPT’s vision and purpose as well as the future of the rehab therapy industry,” says WebPT CEO Nancy Ham. “Rehab therapy has vast potential to improve health outcomes at scale and significantly reduce costs for patients and providers. Currently, however, 90% of people who could benefit from rehab therapy aren’t receiving it. We’re on a mission to change that, and Warburg Pincus is perfectly positioned to help us scale to reach those individuals and affect the industry as a whole.”

“WebPT is a best-in-class rehab therapy platform and represents a significant opportunity for growth given the shift toward value-based care in the rehab therapy market,” says TJ Carella, Managing Director, Warburg Pincus.

“We believe WebPT is a strong addition to our HCIT portfolio and look forward to partnering with Nancy and the entire team to help accelerate growth, advance innovation and support their clients,” adds Amr Kronfol and Andrew Park, Managing Directors at Warburg Pincus.

Co-founder Dr. Heidi Jannenga, PT, DPT, ATC, will assume the role of Chief Clinical Officer while maintaining ownership interest. Jannenga will continue to advise on the company’s strategic direction and product innovation, while advocating for rehab therapy on a national and international scale.

“WebPT set out more than a decade ago to empower the PT, OT and SLP professions and fight for rehab therapy’s rightful place in the healthcare continuum,” says Dr Heidi Jannenga. “We are grateful to Battery Ventures for their impeccable support and guidance, which has helped us grow exponentially over the last five years. While our business has evolved, we’ve stayed true to our mission of empowering rehab therapists to achieve greatness in practice. Now, our new partnership with Warburg Pincus will give us the tools and resources we need to make the greatest possible impact on health care and help rehab therapists expand their reach to the millions of people who could benefit from receiving musculoskeletal care.”

The investment in WebPT comes as the USD35-billion rehab therapy market is projected to expand, influenced by an ageing and active US population and demand for treatment pathways that reduce opioid exposure. Furthermore, the American Academy of Orthopaedic Surgeons reports that an estimated 126.6 million Americans (one in two adults) are affected by a musculoskeletal condition, which costs an estimated USD213 billion in annual treatment, care and lost wages.

Aeris Partners served as the exclusive financial advisor to WebPT and Battery Ventures.

Related Posts:

  • No Related Posts

BNP Paribas Arbitrage SA Purchases Shares of 31800 Aurora Cannabis Inc (NYSE:ACB)

BNP Paribas Arbitrage SA purchased a new stake in Aurora Cannabis Inc (NYSE:ACB) during the 2nd quarter, according to its most recent disclosure …

Aurora Cannabis logoBNP Paribas Arbitrage SA purchased a new stake in Aurora Cannabis Inc (NYSE:ACB) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,800 shares of the company’s stock, valued at approximately $249,000.

A number of other large investors have also bought and sold shares of the business. Janney Montgomery Scott LLC raised its holdings in Aurora Cannabis by 6.0% in the 2nd quarter. Janney Montgomery Scott LLC now owns 31,147 shares of the company’s stock valued at $244,000 after acquiring an additional 1,773 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Aurora Cannabis by 15.2% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,714,926 shares of the company’s stock valued at $21,275,000 after acquiring an additional 357,679 shares during the last quarter. Regal Investment Advisors LLC raised its holdings in Aurora Cannabis by 25.1% in the 2nd quarter. Regal Investment Advisors LLC now owns 44,810 shares of the company’s stock valued at $350,000 after acquiring an additional 8,999 shares during the last quarter. Traynor Capital Management Inc. raised its holdings in Aurora Cannabis by 49.6% in the 2nd quarter. Traynor Capital Management Inc. now owns 18,694 shares of the company’s stock valued at $146,000 after acquiring an additional 6,196 shares during the last quarter. Finally, Brookstone Capital Management raised its holdings in Aurora Cannabis by 45.0% in the 2nd quarter. Brookstone Capital Management now owns 14,715 shares of the company’s stock valued at $115,000 after acquiring an additional 4,570 shares during the last quarter. 9.11% of the stock is currently owned by institutional investors.

Aurora Cannabis stock opened at $5.80 on Tuesday. The firm has a 50 day simple moving average of $6.46 and a 200-day simple moving average of $7.78. Aurora Cannabis Inc has a 1-year low of $4.58 and a 1-year high of $12.52. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.37 and a quick ratio of 1.98. The stock has a market cap of $5.89 billion, a price-to-earnings ratio of 48.33 and a beta of 2.44.

A number of analysts have commented on the stock. Compass Point assumed coverage on shares of Aurora Cannabis in a report on Monday, July 8th. They issued a “neutral” rating for the company. LADENBURG THALM/SH SH assumed coverage on shares of Aurora Cannabis in a report on Wednesday, July 17th. They issued a “buy” rating and a $9.00 price objective for the company. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Wednesday, August 21st. Piper Jaffray Companies assumed coverage on shares of Aurora Cannabis in a report on Monday, August 12th. They issued a “neutral” rating and a $7.00 price objective for the company. Finally, Stifel Nicolaus assumed coverage on shares of Aurora Cannabis in a report on Wednesday, June 5th. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the stock. Aurora Cannabis currently has a consensus rating of “Hold” and a consensus price target of $8.23.

Aurora Cannabis Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Range Trading

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Artificial Intelligence Could Use EKG Data to Measure Our Health

In the not-too-distant future, medical professionals might be able to apply AI to electrocardiogram data in order to measure a patient’s overall health …

In the not-too-distant future, medical professionals might be able to apply AI to electrocardiogram data in order to measure a patient’s overall health status.

This is according to new research published inCirculation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

RELATED: NEW PROMISING NANO-BASED TECHNIQUE TO DETECT CANCER

AI health scans

An electrocardiogram – also called an EKG or ECG – is a test used to measure the electrical activity of the heart. A patient’s sex and age can have an effect on how an EKG turns out.

That’s why the team of researchers built an AI that could determine a patient’s gender and estimate their ‘physiologic age’ – an indicator of overall health that is different fromchronological age.

Using the EKG data of roughly 500,000 patients, the AI was trained to estimate the physiologic age of patients based largely on whether they had suffered various diseases.

“While physicians already consider whether a patient ‘appears [their] stated age’ as part of their baselinephysical examination, the ability to more objectively and consistently assess this may impact healthcare on multiple levels,” study author Suraj Kapa, M.D., director for Augmented and Virtual Reality Innovation at Mayo Clinic in Rochester, said in a press release.

“Being able to more accurately assess overall health status may help doctors determine which patients they should examine further to determine if there are asymptomatic or currently silent diseases that could benefit from early diagnosis and intervention.”

“For people at large, an AI-enhanced electrocardiogram could better show there may be something going on such as a newhealthissue or comorbid condition that they were otherwise unaware of,” Kapa explained.

High accuracy in determining age

The researchers discovered that their AI was able to determine the chronological age group of any patient with 72% accuracy.

“This evidence—that we might be gleaning some sort of ‘physiologic age’—was certainly both surprising and exciting for its potential role in future outcomes research, and may foster a new area of science where we seek to better understand the biologic underpinnings of such a finding,” Kapa said.

Advertisement

In the future, the researchers would like to focus their studies on the wider population, so as to determine how accurately it reads people who are also in very good health.

Related Posts:

  • No Related Posts

Artificial intelligence-enabled EKG could predict overall health status

Artificial intelligence may be able to use EKG data to determine a person’s gender and “physiologic age,” a calculation of a person’s body function that …

Aug. 27 (UPI) — Electrocardiogram, or EKG, is already used to help diagnose heart health. But what if they could also give a glimpse into overall health?

Artificial intelligence may be able to use EKG data to determine a person’s gender and “physiologic age,” a calculation of a person’s body function that doesn’t factor in actual age, according to a study published Tuesday in the journal Circulation: Arrhythmia and Electrophysiology.

“While physicians already consider whether a patient ‘appears [their] stated age’ as part of their baseline physical examination, the ability to more objectively and consistently assess this may impact healthcare on multiple levels,” study author Suraj Kapa, a researcher at Mayo Clinic and study author, said in a news release.

The researchers trained an artificial intelligence technology known as a convolution neural network to recognize input and output EKG data for nearly 500,000 patients. The data included a patient’s chronological age and whether they had any health ailments.

Following the training, they tested it the system on another input date from another 275,000 patients. The network pinpointed the patient’s gender with 90 percent accuracy and chronological age with 72 percent accuracy.

The neural network closely approximated a higher chronological age for patients who had heart attacks, coronary artery disease or other negative outcomes. It also estimated a lower age if the patients who had few or no adverse health events.

“This evidence — that we might be gleaning some sort of ‘physiologic age’ — was certainly both surprising and exciting for its potential role in future outcomes research, and may foster a new area of science where we seek to better understand the biologic underpinnings of such a finding,” Kapa said.

Related Posts:

  • No Related Posts